THYGENX Trademark

Trademark Overview

On Wednesday, August 13, 2014, a trademark application was filed for THYGENX with the United States Patent and Trademark Office. The USPTO has given the THYGENX trademark a serial number of 86365003. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, November 7, 2025. This trademark is owned by Interpace Diagnostics, LLC. The THYGENX trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Human biomedical molecular diagnostic testing, monitoring and reporting services to aid in the diagnosis and resolution of thyroid cancer
thygenx

General Information

Serial Number86365003
Word MarkTHYGENX
Filing DateWednesday, August 13, 2014
Status710 - CANCELLED - SECTION 8
Status DateFriday, November 7, 2025
Registration Number4729279
Registration DateTuesday, April 28, 2015
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 21, 2014

Trademark Statements

Goods and ServicesHuman biomedical molecular diagnostic testing, monitoring and reporting services to aid in the diagnosis and resolution of thyroid cancer

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, November 7, 2025
Primary Code044
First Use Anywhere DateMonday, December 1, 2014
First Use In Commerce DateMonday, December 1, 2014

Trademark Owner History

Party NameInterpace Diagnostics, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressParsippany, NJ 07054
Party NameInterpace Diagnostics, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressParsippany, NJ 07054
Party NameInterpace Diagnostics, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressParsippany, NJ 07054

Trademark Events

Event DateEvent Description
Saturday, August 16, 2014NEW APPLICATION ENTERED
Thursday, August 21, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, September 10, 2014ASSIGNED TO EXAMINER
Wednesday, September 10, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 1, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 21, 2014PUBLISHED FOR OPPOSITION
Tuesday, October 21, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 16, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 20, 2015TEAS STATEMENT OF USE RECEIVED
Wednesday, February 25, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, January 20, 2015USE AMENDMENT FILED
Wednesday, February 25, 2015STATEMENT OF USE PROCESSING COMPLETE
Friday, March 20, 2015ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, March 21, 2015NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, April 28, 2015REGISTERED-PRINCIPAL REGISTER
Wednesday, October 5, 2016ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Thursday, February 6, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, April 28, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, April 29, 2020TEAS SECTION 8 & 15 RECEIVED
Wednesday, July 15, 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, July 15, 2020REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Wednesday, July 15, 2020NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Friday, September 8, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, September 8, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, September 8, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, September 8, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, September 8, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sunday, April 28, 2024COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Friday, November 7, 2025CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9

Related Keywords

thygenx diagnosis services resolution thyroid cancer reporting monitoring biomedical molecular diagnostic